AU704851B2 - Compositions and methods for the prevention and treatment of oral mucositis - Google Patents

Compositions and methods for the prevention and treatment of oral mucositis Download PDF

Info

Publication number
AU704851B2
AU704851B2 AU11629/97A AU1162997A AU704851B2 AU 704851 B2 AU704851 B2 AU 704851B2 AU 11629/97 A AU11629/97 A AU 11629/97A AU 1162997 A AU1162997 A AU 1162997A AU 704851 B2 AU704851 B2 AU 704851B2
Authority
AU
Australia
Prior art keywords
seq
amino acid
present
peptide
basic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU11629/97A
Other languages
English (en)
Other versions
AU1162997A (en
Inventor
Conway C. Chang
De Hwa Chao
John C. Fiddes
Roger Cherng Fu
Chee Liang Gu
David J. Loury
Deborah A. Steinberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ardea Biociences Inc
Original Assignee
IntraBiotics Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/752,853 external-priority patent/US6025326A/en
Application filed by IntraBiotics Pharmaceuticals Inc filed Critical IntraBiotics Pharmaceuticals Inc
Priority claimed from PCT/US1996/018845 external-priority patent/WO1997018827A1/en
Publication of AU1162997A publication Critical patent/AU1162997A/en
Application granted granted Critical
Publication of AU704851B2 publication Critical patent/AU704851B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU11629/97A 1995-11-22 1996-11-22 Compositions and methods for the prevention and treatment of oral mucositis Ceased AU704851B2 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US562346 1990-08-03
US56234695A 1995-11-22 1995-11-22
US64981196A 1996-05-17 1996-05-17
US649811 1996-05-17
US69092196A 1996-08-01 1996-08-01
US08/752853 1996-11-21
US08/752,853 US6025326A (en) 1995-07-07 1996-11-21 Compositions and methods for the prevention and treatment of oral mucositis
PCT/US1996/018845 WO1997018827A1 (en) 1995-11-22 1996-11-22 Compositions and methods for the prevention and treatment of oral mucositis
US690921 2000-10-18

Publications (2)

Publication Number Publication Date
AU1162997A AU1162997A (en) 1997-06-11
AU704851B2 true AU704851B2 (en) 1999-05-06

Family

ID=27504828

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11629/97A Ceased AU704851B2 (en) 1995-11-22 1996-11-22 Compositions and methods for the prevention and treatment of oral mucositis

Country Status (10)

Country Link
EP (1) EP0865292A4 (pt)
JP (1) JP2000501388A (pt)
KR (1) KR19990071547A (pt)
AU (1) AU704851B2 (pt)
BR (1) BR9611759A (pt)
CA (1) CA2238429A1 (pt)
CZ (1) CZ159298A3 (pt)
HU (1) HUP9901183A3 (pt)
IL (1) IL124576A0 (pt)
PL (1) PL326924A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001519766A (ja) * 1996-04-03 2001-10-23 メルク エンド カンパニー インコーポレーテッド ファルネシルタンパク質トランスフェラーゼの阻害剤
EP1765293B1 (en) * 2004-06-24 2014-10-01 Idexx Laboratories, Inc. Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
JP5032003B2 (ja) * 2005-06-15 2012-09-26 株式会社琉球バイオリソース開発 口腔粘膜用の鎮痛・抗炎症トローチ剤

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102870A (en) * 1989-04-14 1992-04-07 Schering Ag Treatment and prevention of oral mucositis with growth factors
WO1995003325A1 (en) * 1993-07-20 1995-02-02 University Of California, Los Angeles Protegrins
US5464823A (en) * 1993-07-20 1995-11-07 The Regents Of The University Of California Mammalian antibiotic peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002287A1 (en) * 1995-07-06 1997-01-23 Intrabiotics Pharmaceuticals, Incorporated Parevins and tachytegrins

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102870A (en) * 1989-04-14 1992-04-07 Schering Ag Treatment and prevention of oral mucositis with growth factors
WO1995003325A1 (en) * 1993-07-20 1995-02-02 University Of California, Los Angeles Protegrins
US5464823A (en) * 1993-07-20 1995-11-07 The Regents Of The University Of California Mammalian antibiotic peptides

Also Published As

Publication number Publication date
EP0865292A1 (en) 1998-09-23
IL124576A0 (en) 1999-01-26
JP2000501388A (ja) 2000-02-08
PL326924A1 (en) 1998-11-09
KR19990071547A (ko) 1999-09-27
CZ159298A3 (cs) 1998-12-16
AU1162997A (en) 1997-06-11
HUP9901183A2 (hu) 1999-07-28
EP0865292A4 (en) 2002-01-02
HUP9901183A3 (en) 1999-11-29
CA2238429A1 (en) 1997-05-29
BR9611759A (pt) 1999-12-28

Similar Documents

Publication Publication Date Title
US6025326A (en) Compositions and methods for the prevention and treatment of oral mucositis
WO1997018827A1 (en) Compositions and methods for the prevention and treatment of oral mucositis
CN114269771B (zh) Romo1来源抗微生物肽及其变体
US8044022B2 (en) Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
US20170073371A1 (en) Antimicrobial peptides
AU764218B2 (en) Threonine-containing protegrins
AU704851B2 (en) Compositions and methods for the prevention and treatment of oral mucositis
MXPA98004079A (en) Compositions and methods for the prevention and treatment of mucositis or
US8492515B2 (en) Antibacterial peptides active in systemic infections
WO2020198834A1 (en) Treatment of microbial infections using scpppq1 proteins and derived peptides
KR20080051439A (ko) 세포 용혈활성이 감소된 항균 펩타이드
JP2005532784A (ja) 新規の抗菌ボリシンペプチド